Experts in monoclonal antibodies biomanufacturing !

From mg up to several grams, with a process and a quality grade adapted to your applications Contactez-nous pour plus d’informations !


RD-Biotech, a complete platform from DNA to antibody

For your antibody development projects, for applications in immunotherapy, diagnostics, research: contact our team of experts in molecular biology and antibody engineering: Contact us for more information!


RD-Biotech: laureate “France Relance, volet Résilience”

On Thursday 30 September 2021, RD-Biotech was pleased to welcome Mr Jean-François Colombet, Prefect of the Doubs, as part of the France Relance plan, Résilience category.
Selected by the French government as part of the France Relance plan, the project to build a GMP-grade production unit will complement our current R&D grade and "High Quality Grade" ("GMP like") plasmid DNA biomanufacturing capacities, in order to answer the growing of market demand in new therapies. Construction will soon begin on the Temis Santé site

Link to the article: RD-Biotech: lauréat sur le volet Résilience - santé


RD-Biotech is here to help you in your projects related to Covid-19!

Development / Production of monoclonal or recombinant antibodies - Expression vector construction - Antigen expression - DNA plasmid production...: Contact us for more information!